Currently, the IBS treatment market is naïve and underpenetrated, with only 4 products indicated for IBS in the 7MM.
Managed care and hospital decision-makers are in a key position to “move the needle” at the system level on improving adult immunization coverage rates in the United States.
More than one-third of reproductive-aged women enrolled in Medicaid, and more than a quarter of those with private insurance, filled a prescription for an opioid pain medication each year during 2008 to 2012, according to a recent...

FDA APPROVALS
FDA approves Corlanor to treat heart ...

FDA has approved ivabradine (Corlanor, Amgen) to reduce hospitalization due to worsening heart failure. Corlanor is an ...

FDA approves Copaxone for MS; ...
FDA approves breath test to help ...
FDA drug approvals-April 2015

CLINICAL
FDA approves changes to hep C drug ...

FDA has approved changes to the hepatitis C antiviral simeprevir (Olysio, Janssen) label to include new warnings about ...

FDA approves Corlanor to treat heart ...
Study: Reduce long-term care use ...
Study: Babies exposed to narcotic ...

DRUGS IN PERSPECTIVE
Drugs in Perspective: Opdivo (nivolumab)

On December 22, 2014, Opdivo (nivolumab) was approved by FDA with a breakthrough therapy designation. Nivolumab is the ...

Drugs in Perspective: Myalept ...
Drugs in Perspective: Otezla ...
Drugs in Perspective: Zykadia ...

Latest Tweets Follow